company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4383856.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,389253.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,566531.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3428072.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3428072.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37060.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37060.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37060.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4861285.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4861285.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4861285.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:20:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1396153.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4168384.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4933.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1182207.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2426040.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-555204.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-555204.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448239.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-448239.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-448239.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,72728904.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,72728904.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,72728904.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,71725461.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6756924.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10916.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1065325.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4875436.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-805247.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-805247.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4478537.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4478537.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4478537.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-273528.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-291701.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-565229.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-565229.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5849013.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9015645.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9015645.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,153941.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1704867.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22331739.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15174902.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15174902.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6733126.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6733126.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6733126.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1147414.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1147414.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1147414.0
Spark Therapeutics Inc,ONCE,,0001609351,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7294362.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9733507.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9733507.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,370570.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2766118.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2343097.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8939916.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8939916.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1685771.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1685771.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1685771.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,170470842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,170470842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,170470842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:24:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,159845155.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14336842.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,426607.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3108722.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,420824.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10380689.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10380689.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-826586.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-826586.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-826586.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-157407.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-157407.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-157407.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11364682.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16900560.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,448392.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2967409.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3068976.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10415783.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10415783.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-565379.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-565379.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-565379.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,92924.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,92924.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,92924.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10888238.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6154869.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,487414.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4912233.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16986617.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17741839.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17741839.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1444033.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1444033.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1444033.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100557264.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100557264.0
Spark Therapeutics Inc,ONCE,,0001609351,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81371392.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25576711.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,744058.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4684177.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12430145.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7718331.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7718331.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4473966.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5907850.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10381816.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10381816.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-657331.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,196180.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-461151.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-461151.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:27:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18561298.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28676115.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,911730.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6467397.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2039328.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23336316.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23336316.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1178421.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3393.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-153954426.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-155136240.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-155136240.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,657331.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,127024270.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,848328.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,128529929.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,128529929.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49942627.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32562407.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,957632.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5607068.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5206331.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20791376.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20791376.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1813716.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119055592.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-115869308.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-115869308.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2249557.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2249557.0
Spark Therapeutics Inc,ONCE,,0001609351,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-134411127.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1031000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9719000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8421000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33118000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33118000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24225000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24780000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1675000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1675000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3434000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3359000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3359000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:13:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31428000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74360000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74360000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1195000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2048000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42760000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42760000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4991000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3457000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42312000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101587000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,50827000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,50827000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-75000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-471000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1734000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1188000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1188000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,62000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9317000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65012000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65012000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1273000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17258000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5434000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51915000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51915000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1674000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1363000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-308210000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,80458000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-230789000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-230789000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,150000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,471000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,226000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,381287000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11876000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,394010000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,392292000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-68000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,109622000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61821000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61821000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1401000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12651000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21070000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26699000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26743000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-759000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3397000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66739000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44800000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26095000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26095000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3435000.0
Spark Therapeutics Inc,ONCE,,0001609351,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49505000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46373000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46373000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1507000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,126989000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29122000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,53001000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,53001000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4141000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-110882000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94673000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22350000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22350000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-77000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1756000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,762000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1332000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,261000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,261000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:07:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30912000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,80165000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80165000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1618000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-120388000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10160000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48765000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48765000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3988000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118544000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,110000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125439000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,112907000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,112907000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1038000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10414000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9298000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9298000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73440000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47357000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1695000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6873000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6517000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32272000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32272000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6791000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-131143000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,132055000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5879000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5879000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-478000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,50000000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,805000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1383000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,51632000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,51632000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13481000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65257000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65257000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2080000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,75022000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-54390000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42545000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42527000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18901000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-300000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-170420000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,164106000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25515000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25515000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-79000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-163000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2002000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1760000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1760000.0
Spark Therapeutics Inc,ONCE,,0001609351,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66282000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54358000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54358000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2432000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6158000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13669000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32099000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32099000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4288000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75343000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96016000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16385000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16385000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-80000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15314000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,563000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11607000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3224000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3224000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:07:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18938000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64230000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2587000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12220000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-551000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49974000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49974000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5945000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-809000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101359000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,94605000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,94605000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-80000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1671000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4929000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3178000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3178000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47809000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66602000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66602000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2521000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12811000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32895000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18375000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18375000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7444000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,129000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108289000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,100974000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,100974000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1581000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-810000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1374000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1017000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1017000.0
Spark Therapeutics Inc,ONCE,,0001609351,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81582000.0
